Nur Ink Innovations Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
NURI
IL0011757288
Specialty Chemicals
Sales 2022 | - | Sales 2023 | - | Capitalization | 53.72M 195M |
---|---|---|---|---|---|
Net income 2022 | -11M -39.98M | Net income 2023 | -12M -43.61M | EV / Sales 2022 | - |
Net cash position 2022 | 17.77M 64.57M | Net cash position 2023 | 7.22M 26.26M | EV / Sales 2023 | - |
P/E ratio 2022 |
-13.6
x | P/E ratio 2023 |
-
| Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 43.2% |
Managers | Title | Age | Since |
---|---|---|---|
Moshe Nur
CEO | Chief Executive Officer | 74 | 18-11-13 |
David Gerbi
DFI | Director of Finance/CFO | 45 | 21-01-25 |
Moshe Nakash
CTO | Chief Tech/Sci/R&D Officer | 60 | 22-03-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 19-09-01 | |
Sarel Ashkenazi
BRD | Director/Board Member | 51 | 21-01-25 |
Moshe Nur
CEO | Chief Executive Officer | 74 | 18-11-13 |
1st Jan change | Capi. | |
---|---|---|
+3.33% | 3.77B | |
+9.90% | 1.84B | |
+27.62% | 1.13B | |
-14.92% | 803M | |
+67.80% | 763M | |
+27.97% | 633M | |
+3.46% | 575M | |
+31.30% | 590M | |
-21.12% | 559M |